GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $65,000 | -22.6% | 185,945 | +3.6% | 0.00% | – |
| Q2 2016 | $84,000 | -62.0% | 179,495 | +10.6% | 0.00% | -100.0% |
| Q1 2016 | $221,000 | -6.4% | 162,220 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $236,000 | +2.2% | 160,845 | +10.2% | 0.00% | 0.0% |
| Q3 2015 | $231,000 | -3.3% | 145,995 | +3.8% | 0.00% | 0.0% |
| Q2 2015 | $239,000 | +38.2% | 140,600 | +12.9% | 0.00% | – |
| Q1 2015 | $173,000 | +12.3% | 124,585 | +21.8% | 0.00% | – |
| Q4 2014 | $154,000 | -24.9% | 102,285 | +2.9% | 0.00% | -100.0% |
| Q3 2014 | $205,000 | -34.1% | 99,410 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $311,000 | +44.7% | 101,510 | +18.2% | 0.00% | 0.0% |
| Q1 2014 | $215,000 | -51.8% | 85,901 | -4.5% | 0.00% | 0.0% |
| Q4 2013 | $446,000 | +129.9% | 89,971 | +5.3% | 0.00% | 0.0% |
| Q3 2013 | $194,000 | +14.8% | 85,471 | +12.4% | 0.00% | 0.0% |
| Q2 2013 | $169,000 | – | 76,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |